BioNTech SE (22UA) Drug Pipeline

The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness

A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.

BioNTech SE DE:22UA is currently developing the following drugs: Carboplatin, Etoposide, Obrixtamig, Pumitamig, Bnt327, Bnt162b2 Vaccine, Tdap Vaccine, Bnt168, Bnt3214, Bnt351, Docetaxel, Prednisone/Prednisolone, Bnt324, Db-1311, Bnt166a, Pembrolizumab, Pumitamig, Durvalumab, Pumitamig, Atezolizumab, Bevacizumab, Ipilimumab, Pumitamig, Nivolumab, Ipilimumab, Pumitamig, Cabozantinib, Temozolomide, Pumitamig, Bevacizumab, Bnt327, Pm8002, Bnt162b2 Vaccine, Gemcitabine, Nab-Paclitaxel, Mfolfirinox, Pumitamig, Bnt162b2, Nivolumab, Folfox, Pumitamig, Capox, Bevacizumab, Folfiri, Folfox, Pumitamig, Capox, Bnt329, Ca19-9-Targeting Monoclonal Antibody, Gemcitabine, Carboplatin, Eribulin, Pumitamig, Nab-Paclitaxel/Paclitaxel, Bnt327, Bnt3212, Pembrolizumab, Soc, Bnt327, Bnt326, Pm8002, Chemotherapy Regimen 1, Chemotherapy Regimen 2, Bevacizumab, Bnt327, Bnt314, Soc Chemotherapy Treatment 1, Soc Chemotherapy Treatment 2, Paroxetine, Itraconazole, Bnt327, Bnt326, Cldn6 Car-T, Cldn6 Rna-Lpx, Db-1305/Bnt325, Bnt327, Db-1311/Bnt324, Bnt327, Bnt324, Docetaxel, Pumitamig, Bnt327, Bnt323, Investigational Influenza Vaccine, Investigational Covid-19 Vaccine, Investigational Influenza And Covid-19 Combination Vaccine, Licensed Influenza Vaccine 1, Licensed Influenza Vaccine 2, Licensed Influenza Vaccine 3, Licensed Covid-19 Vaccine, Bnt317 Dl1, Bnt317 Dl2, Bnt317 Dl3, Bnt317 Dl4, Bnt317 Dl5, Bnt317 Dl6, Bnt317 Dl7, Atezolizumab, Carboplatin, Etoposide, Bnt327, Pembrolizumab, Pemetrexed, Paclitaxel, Carboplatin, Pumitamig, Covid-19 Vaccine, Investigational Influenza Vaccine, Licensed Influenza Vaccine 1, Licensed Influenza Vaccine 2, Influenza And Covid Combination Vaccine, Nivolumab, Saline, Autogene Cevumeran, Bnt331, Gemcitabine, Paclitaxel, Carboplatin, Eribulin, Bnt327 Dose Level 1, Nab-Placlitaxel, Bnt327 Optimized Dose, Bnt327 Equivalent Q3w Dose, Paclitaxel, Carboplatin, Topotecan, Etoposide, Bnt327 Dose Level 1, Bnt327 Dose Level 2, Pembrolizumab, Standard Chemotherapy, Gen1055. These drug candidates are in various stages of clinical development as the company works toward FDA approval.